Aspen Pharmacare Holdings Limited APNHY Stock
Aspen Pharmacare Holdings Limited Price Chart
Aspen Pharmacare Holdings Limited APNHY Financial and Trading Overview
| Aspen Pharmacare Holdings Limited stock price | 5.54 USD |
| Previous Close | 9.96 USD |
| Open | 9.97 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 9.96 - 9.96 USD |
| 52 Week Range | 7.4 - 10.29 USD |
| Volume | 66 USD |
| Avg. Volume | 209 USD |
| Market Cap | 4.43B USD |
| Beta (5Y Monthly) | 0.667808 |
| PE Ratio (TTM) | 14.02817 |
| EPS (TTM) | -0.14 USD |
| Forward Dividend & Yield | 0.18 (1.80%) |
| Ex-Dividend Date | September 22, 2022 |
| 1y Target Est | N/A |
APNHY Valuation Measures
| Enterprise Value | 23.18B USD |
| Trailing P/E | 14.02817 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.11548306 |
| Price/Book (mrq) | 0.058824923 |
| Enterprise Value/Revenue | 0.604 |
| Enterprise Value/EBITDA | 2.475 |
Trading Information
Aspen Pharmacare Holdings Limited Stock Price History
| Beta (5Y Monthly) | 0.667808 |
| 52-Week Change | 15.14% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.29 USD |
| 52 Week Low | 7.4 USD |
| 50-Day Moving Average | 9.45 USD |
| 200-Day Moving Average | 8.7 USD |
APNHY Share Statistics
| Avg. Volume (3 month) | 209 USD |
| Avg. Daily Volume (10-Days) | 220 USD |
| Shares Outstanding | 444.95M |
| Float | 294.06M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.0020% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 3.26 |
| Trailing Annual Dividend Yield | 32.73% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.25059998 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 15.11% |
| Operating Margin (ttm) | 21.26% |
| Gross Margin | 46.54% |
| EBITDA Margin | 24.39% |
Management Effectiveness
| Return on Assets (ttm) | 4.28% |
| Return on Equity (ttm) | 7.88% |
Income Statement
| Revenue (ttm) | 38.37B USD |
| Revenue Per Share (ttm) | 85.88 USD |
| Quarterly Revenue Growth (yoy) | -1.19% |
| Gross Profit (ttm) | 18.29B USD |
| EBITDA | 9.36B USD |
| Net Income Avi to Common (ttm) | 5.8B USD |
| Diluted EPS (ttm) | 0.71 |
| Quarterly Earnings Growth (yoy) | -20.39% |
Balance Sheet
| Total Cash (mrq) | 8.05B USD |
| Total Cash Per Share (mrq) | 18.11 USD |
| Total Debt (mrq) | 26.8B USD |
| Total Debt/Equity (mrq) | 35.63 USD |
| Current Ratio (mrq) | 2.396 |
| Book Value Per Share (mrq) | 169.316 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 5.32B USD |
| Levered Free Cash Flow (ttm) | 1.22B USD |
Profile of Aspen Pharmacare Holdings Limited
| Country | United States |
| State | N/A |
| City | Durban |
| Address | Aspen Place |
| ZIP | N/A |
| Phone | 27 31 580 8600 |
| Website | https://www.aspenpharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 8580 |
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Q&A For Aspen Pharmacare Holdings Limited Stock
What is a current APNHY stock price?
Aspen Pharmacare Holdings Limited APNHY stock price today per share is 5.54 USD.
How to purchase Aspen Pharmacare Holdings Limited stock?
You can buy APNHY shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aspen Pharmacare Holdings Limited?
The stock symbol or ticker of Aspen Pharmacare Holdings Limited is APNHY.
Which industry does the Aspen Pharmacare Holdings Limited company belong to?
The Aspen Pharmacare Holdings Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Aspen Pharmacare Holdings Limited have in circulation?
The max supply of Aspen Pharmacare Holdings Limited shares is 444.02M.
What is Aspen Pharmacare Holdings Limited Price to Earnings Ratio (PE Ratio)?
Aspen Pharmacare Holdings Limited PE Ratio is now.
What was Aspen Pharmacare Holdings Limited earnings per share over the trailing 12 months (TTM)?
Aspen Pharmacare Holdings Limited EPS is -0.14 USD over the trailing 12 months.
Which sector does the Aspen Pharmacare Holdings Limited company belong to?
The Aspen Pharmacare Holdings Limited sector is Healthcare.


